Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
17.21
+0.31 (+1.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Why NovoCure Stock Is Sinking This Week
October 28, 2021
Investors weren't happy with the company's Q3 update.
Via
The Motley Fool
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
October 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...
Via
Benzinga
Recap: NovoCure Q3 Earnings
October 28, 2021
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update
October 28, 2021
From
Novocure
Via
Business Wire
Earnings Scheduled For October 28, 2021
October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...
Via
Benzinga
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian Cancer
October 28, 2021
From
Novocure
Via
Business Wire
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual Meeting
October 21, 2021
From
Novocure
Via
Business Wire
Bitcoin Futures Arrive
October 19, 2021
Today you can finally hold Bitcoins via an exchange-traded fund.
Via
Talk Markets
More Chinese Trouble
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now
October 14, 2021
Novocure's stock keeps sliding, but the company continues to perform.
Via
The Motley Fool
This Company's Device is Becoming Essential to Cancer Treatment -- Why Is the Stock Slumping?
October 12, 2021
Is it time to buy this stock nearly at its 52 week low?
Via
The Motley Fool
Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks
October 11, 2021
On Friday's "Mad Money Lightning ...
Via
Benzinga
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
October 04, 2021
From
Novocure
Via
Business Wire
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
Novocure to Report Third Quarter 2021 Financial Results
October 04, 2021
From
Novocure
Via
Business Wire
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
Novocure Ltd (NASDAQ: NVCR) has entered into a clinical trial collaboration agreement with Roche Holdings AG (OTC: RHHBY) to develop Tumor Treating...
Via
Benzinga
Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer
September 14, 2021
From
Novocure
Via
Business Wire
Pressure Day
September 13, 2021
Today a recovery came to markets with a particular impact on uranium shares.
Via
Talk Markets
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
A Weak Week
September 10, 2021
Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.
Via
Talk Markets
Delta Variant Fears Continue
September 09, 2021
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.
Via
Talk Markets
This Promising Healthcare Stock Is Down 50% From Its Highs; Should You Buy the Dip?
September 09, 2021
Novocure has been fantastic for investors, up over 1,600% in the past five years. But in the past six months, shareholders have been on a roller coaster.
Via
The Motley Fool
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
September 09, 2021
From
Novocure
Via
Business Wire
Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
September 02, 2021
From
Novocure
Via
Business Wire
Novocure Appoints Bill Burke as Chief Human Resources Officer
September 01, 2021
From
Novocure
Via
Business Wire
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
What's Next for Novocure?
August 13, 2021
The company has several key data readouts on the way.
Via
The Motley Fool
Delta Outbreak
August 04, 2021
The US market was droopy because of poor private sector jobless numbers.
Via
Talk Markets
Cramer Advises Viewers On Palantir, SoFi And More
August 04, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer....
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.